-
Abbott Laboratories' (ABT) Overweight Rating Reaffirmed at Barclays
Source: Buzz FX / 27 Jan 2025 07:26:18 America/Chicago
Abbott Laboratories' (ABT) Overweight Rating Reaffirmed at Barclays Written by MarketBeat January 27, 2025 Share Link copied to clipboard. Abbott Laboratories ( NYSE:ABT - Get Free Report ) 's stock had its "overweight" rating reaffirmed by
Read more...